Nunaps
PrivateLast Round
Series B
Jan 1, 2025
Total Funding Raised
$13.47M
Company Overview
Nunaps is a digital therapeutics company that develops software-based medical devices and platforms to treat and manage neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nunaps Comparables
Compare Nunaps with similar companies based on industry and business-model similarity.
Nunaps Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 1, 2025 | ||||
| Series A | Jan 5, 2020 | ||||
| Seed | Dec 1, 2017 |
Nunaps Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hanwha Investment & Securities | Series B |
| K2 Investment Partners | Series A |
| Smilegate Investment | Series B |
| Prodigy Investment | VC Round |
| Company K Partners | Seed, Series A, Series B |
| Woori Venture Partners Co., Ltd. | Series B |
| Korea Development Bank | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Grew 200% QoQ, from 2 to 6 employees.
- Mar 14, 2026
Grew 500% QoQ from 1 to 6 employees.
Recent news
Latest coverage and updates
- receives_financingAug 18, 2026
Nunaps Inc. receives financing of $15.5M in Series B.
- is_developingAug 18, 2026
Nunaps Inc. is developing Lexure: Digital therapeutic for patients with language disorders.
Nunaps Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nunaps's valuation, stock price, and market status.
Is Nunaps a public or private company?
Nunaps is a private company.
What is the current stock price of Nunaps?
Nunaps is a private company with no public stock price. No recent secondary market data is available.
How much is Nunaps worth (valuation)?
Valuation information for Nunaps is not publicly available.
Can I buy Nunaps stock?
Nunaps shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nunaps's last funding round?
Nunaps's most recent funding round was Series B on January 1, 2025.
Who are the main investors in Nunaps?
Key investors in Nunaps include Hanwha Investment & Securities, K2 Investment Partners, Smilegate Investment, Prodigy Investment, Company K Partners.
Will Nunaps IPO soon?
No public IPO plans have been announced for Nunaps.
How can I track Nunaps secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nunaps's secondary market activity and sign up for updates.